Bitetti Teresa Marie
President, OBU at TAK
- Sold, on record
- $855k
- Dollars the filings state
- Form 4 sales
- 1
- Latest Aug 10, 2026
- Form 144 notices
- 5
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- TAKTAKEDA PHARMACEUTICAL CO LTDPresident, OBU
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice TAKNoticeJul 10, 2023 2023
Filed to sell 46,424 shares ($719k)
Bitetti Teresa Marie, President, Global Oncology Business Unit
No 10b5-1 planFirst sale on recordFiling
- 2 Form 144 notice TAKNoticeJul 10, 2024 +366 days
Filed to sell 38,479 shares ($507k)
Bitetti Teresa Marie, President, Global Oncology Business Unit
No 10b5-1 planFirst sale on recordFiling
- 3 Form 144 notice TAKNoticeJul 9, 2025 +364 days
Filed to sell 52,649 shares ($812k)
Bitetti Teresa Marie, President, Global Oncology Business Unit
No 10b5-1 planFirst sale on recordFiling
- 4 Form 144 notice TAKNoticeDec 5, 2025 +149 days
Filed to sell 87,023 shares ($1.2M)
Bitetti Teresa Marie, President, Global Oncology Business Unit
No 10b5-1 planFirst sale on recordFiling
- 5 Form 144 notice TAKNoticeJul 13, 2026 +220 days
Filed to sell 54,210 shares ($908k)
Bitetti Teresa Marie, President, Global Oncology Business Unit
No 10b5-1 planFirst sale on recordFiling
- 6 Form 4 sale TAKNo planAug 10, 2026 +28 days
Sold 50,012 shares at $17.10 ($855k)
Bitetti Teresa Marie, President, OBU
No 10b5-1 planSold 16.6% of holdings ($5.2M position)252,010 shares leftFirst sale on recordFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (6)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Aug 12, 2026 | TAK | President, OBU | Form 4 sale | 50,012 | $855k | 16.6% | No plan | SEC |
| Jul 13, 2026 | Jul 13, 2026 | TAK | President, Global Oncology Business Unit | Form 144 notice | 54,210 | $908k | Notice | SEC | |
| Dec 5, 2025 | Dec 5, 2025 | TAK | President, Global Oncology Business Unit | Form 144 notice | 87,023 | $1.2M | Notice | SEC | |
| Jul 9, 2025 | Jul 9, 2025 | TAK | President, Global Oncology Business Unit | Form 144 notice | 52,649 | $812k | Notice | SEC | |
| Jul 10, 2024 | Jul 10, 2024 | TAK | President, Global Oncology Business Unit | Form 144 notice | 38,479 | $507k | Notice | SEC | |
| Jul 10, 2023 | Jul 10, 2023 | TAK | President, Global Oncology Business Unit | Form 144 notice | 46,424 | $719k | Notice | SEC |